Cargando…
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis
Objective To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. Design Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while...
Autores principales: | Windecker, Stephan, Stortecky, Stefan, Stefanini, Giulio G, daCosta, Bruno R, Rutjes, Anne Wilhelmina, Di Nisio, Marcello, Siletta, Maria G, Maione, Ausilia, Alfonso, Fernando, Clemmensen, Peter M, Collet, Jean-Philippe, Cremer, Jochen, Falk, Volkmar, Filippatos, Gerasimos, Hamm, Christian, Head, Stuart, Kappetein, Arie Pieter, Kastrati, Adnan, Knuuti, Juhani, Landmesser, Ulf, Laufer, Günther, Neumann, Franz-Joseph, Richter, Dimitri, Schauerte, Patrick, Sousa Uva, Miguel, Taggart, David P, Torracca, Lucia, Valgimigli, Marco, Wijns, William, Witkowski, Adam, Kolh, Philippe, Juni, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066935/ https://www.ncbi.nlm.nih.gov/pubmed/24958153 http://dx.doi.org/10.1136/bmj.g3859 |
Ejemplares similares
-
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading?
por: Costa, Francesco, et al.
Publicado: (2015) -
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy
por: Briceno, Natalia, et al.
Publicado: (2016) -
Revascularisation for Ischaemic Cardiomyopathy
por: Li Kam Wa, Matthew E, et al.
Publicado: (2023) -
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
por: Navarese, Eliano P, et al.
Publicado: (2021) -
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials
por: Valgimigli, Marco, et al.
Publicado: (2021)